Targeted drug delivery system utilizing plasma and nanosecond pulsed electric field

Through plasma and nanosecond pulsed electric field technology, the problems of irritation and difficulty in implanting skin in traditional technology are solved, and the efficient and precise transdermal delivery of drugs is achieved, providing a painless and non-invasive Targeted drug delivery system improves the permeability and absorption efficiency of drugs.

CN118925048APending Publication Date: 2024-11-12SHANGHAI HEGUANGZHI MEDICAL TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410997796.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

In the prior art, the implantation of the skin is irritating, difficult to operate, and complex structure. Traditional transdermal technology is limited to chemical and physical methods, making it difficult to achieve efficient and accurate transdermal drug delivery.

Method used

Using plasma and nanosecond pulsed electric field technology, the charge distribution and cell membrane permeability of the skin are regulated by controlling the electric field parameters, forming temporary nanopores, promoting drug penetration through the skin, and using plasma active particles to enhance skin microcirculation to achieve drug Accurate and controllable release.

Benefits of technology

It improves the permeability and absorption efficiency of the drug, achieves a painless and non-invasive drug delivery method, reduces the risk of infection and operational complexity, and enhances the treatment effect and patient comfort.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118925048A_ABST
    Figure CN118925048A_ABST
Patent Text Reader

Abstract

The invention creatively discloses a targeted drug delivery system using plasma and a nanosecond pulsed electric field, relates to the technical field of targeted drug delivery, and solves the technical problems that in the prior art, the system needs to be implanted into skin, has irritation, is high in operation difficulty and is complex in structure, the system comprises a control unit and a drug delivery hand tool, the control unit is connected with a plasma generation assembly, the control unit is connected with a medicine supply assembly, and the plasma generation assembly and the medicine supply assembly are respectively connected to the medicine delivery hand tool. According to the invention, the permeability of a medicine in skin and tissues can be improved, so that the percutaneous absorption of the medicine is effectively promoted; the drug delivery speed is high, the effect taking speed is high, and the effect is more direct and efficient; the accuracy and controllability of drug delivery are improved through drug delivery in a pulse mode; the system can give full play to biological activity; the application of the system does not need to damage the skin and does not need injection or operation, so that the system is painless, non-invasive, convenient and safe to use and free of risk of cross infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of targeted drug delivery, and specifically is a targeted drug delivery system utilizing plasma and nanosecond pulse electric fields. Background Art

[0002] The technical field involved in the invention is that the skin, as the outermost protective barrier of the human body, is formed by the close combination of the epidermis and the dermis, wherein the epidermis includes the stratum corneum, the stratum lucidum, the stratum granulosum and the stratum germinativum. The stratum corneum is the main barrier, which is composed of multiple layers of keratinized epithelial cells to prevent external substances from entering the body. The traditional transdermal drug delivery system is limited by the skin barrier, and the advantages of the transdermal drug delivery system are that it is not affected by digestive tract factors, avoids the first-pass effect, and can control the drug delivery rate. However, most drugs are difficult to penetrate the skin, so it is necessary to adopt a transdermal technology.

[0003] Currently, commonly used permeation technologies include chemical permeation and physical permeation, such as microneedles, electroporation, lasers, etc. These technologies can break the barrier of the stratum corneum and promote the transdermal absorption of drugs. However, these technologies have certain limitations, such as irritation, complexity and high cost. Therefore, new targeted drug delivery technologies have emerged, among which the use of plasma and nanosecond pulse electric field technology for targeted drug delivery is an innovative method. By adjusting the electric field state and parameters, this technology can control the penetration rate and release rate of active substances in the skin to achieve a more precise drug delivery effect. This system can quickly and efficiently promote the transdermal absorption of drugs, and is particularly suitable for large molecule drugs and other active agents that are not easy to penetrate the skin. Through this technology, the traditional injection route can be replaced, the absorption rate and therapeutic effect of drugs can be improved, and it will bring broader application prospects to the field of targeted drug delivery.

[0004] For example, the invention named Implantable Targeted Drug Delivery System with publication number CN113289206A includes an interventional catheter, a drug delivery channel is formed inside the interventional catheter, a pressure sensor and a drug delivery valve connected to the drug delivery channel are arranged at the distal end of the interventional catheter; a drug delivery device, the drug delivery device includes a drug delivery pump and a drug delivery controller, the drug delivery pump is connected to the proximal end of the interventional catheter, the drug delivery controller is respectively connected to the drug delivery pump and the pressure sensor, the drug delivery controller receives the pressure signal inside the human tissue monitored by the pressure sensor, and adjusts the amount of antihypertensive drug delivered to the human tissue by the drug delivery pump through the drug delivery valve according to the pressure signal.

[0005] The existence of the prior art requires implantation into the skin which is irritating.

[0006] For example, the invention named targeted drug delivery needle clamping navigation device and targeted drug delivery treatment system, with publication number CN113952009B, includes: a drug delivery needle fixing sleeve, having a guide channel for guiding the insertion of the syringe of the drug delivery needle and limiting the insertion path of the syringe, the guide channel is provided with a visual structure that can identify the scale on the syringe; a needle limiting sleeve, fixedly connected to the end of the drug delivery needle fixing sleeve, the needle limiting sleeve is provided with at least one first limiting hole arranged along the insertion direction of the drug delivery needle and adapted to the size of the needle, and the at least one first limiting hole limits the insertion path of the needle.

[0007] The existing technology has the technical problems of being difficult to operate and having a complex structure. Summary of the invention

[0008] In view of the shortcomings of the prior art, the present invention provides a targeted drug delivery system using plasma and nanosecond pulse electric fields, which solves the technical problems of the prior art that the drug needs to be implanted into the skin, is irritating, is difficult to operate, and has a complex structure.

[0009] To achieve the above objectives, the present invention is implemented through the following technical solutions: a targeted drug delivery system using plasma and nanosecond pulse electric field, including a control unit and a drug delivery handpiece, the control unit controls the parameters of plasma generation and nanosecond pulse electric field application, such as frequency, voltage and duration, the control unit is connected to a plasma generating component, the control unit is connected to a drug supply component, the plasma generating component and the drug supply component are respectively connected to the drug delivery handpiece, and are used to control the substance to be transdermally absorbed to enter the skin or subcutaneous tissue.

[0010] Preferably, the plasma generating component includes a nanosecond pulse generator, which provides a nanosecond pulse electric field. The nanosecond dosing generator is connected to a control unit, which is connected to a plasma generator, which generates and maintains the required plasma, and the plasma generator is connected to a dosing handpiece.

[0011] Preferably, the drug supply assembly includes a data processing unit, which is connected to the control unit, and the data processing unit is connected to a drug supply unit for supplying drugs that need to be transdermally administered and delivering them to the vicinity of the plasma channel, and the drug supply unit is connected to a drug delivery handpiece.

[0012] Preferably, the data processing unit is connected to a user interaction unit, and the user interaction unit is provided with a touch panel.

[0013] Preferably, the control unit is connected to an electric energy supply component, the electric energy supply component includes a battery and a power supply, the control unit is connected to the battery, and the battery is connected to the power supply.

[0014] Beneficial Effects

[0015] The invention provides a targeted drug delivery system using plasma and nanosecond pulse electric field. The invention temporarily changes the charge distribution on the skin surface and the permeability of the cell membrane by generating local micro-discharges. This change can make it easier for drugs to pass through the skin barrier, thereby improving the permeability of the drug. The nanosecond pulse electric field can generate a high-intensity electric field in a very short time, and this electric field can form temporary nanopores (nanosecond electroporation) on the cell membrane, making it easier for drug molecules to enter the cell. This transient pore will recover quickly after the electric field action ends, thereby avoiding permanent damage to the cell. The active particles of plasma, such as NO, can promote the increase of skin microcirculation, which is conducive to the diffusion and absorption of drugs. In addition, plasma can also make it easier for drugs to reach the deep layer of the skin by removing stratum corneum cells on the skin surface. By applying a short-term high-intensity electric field on the skin, the nanosecond pulse electric field can significantly enhance the permeability of the skin cell membrane, allowing the drug to quickly pass through the skin barrier to reach the target tissue. By combining plasma and nanosecond pulse electric field, the release and absorption of drugs can be more accurately controlled. Plasma is used to initially change the permeability of the skin, and nanosecond pulsed electric fields are used to further enhance the permeability of cell membranes and the efficiency of drug molecules entering cells; nanosecond pulsed electric fields can be applied in pulses at set frequencies and intensities, which makes drug release more controllable and precise, avoiding the unevenness and uncontrollability of drug release in traditional methods; since this system does not require damage to the skin, injections or surgery, and only promotes drug absorption through the physical effects of plasma and electric fields, it is a painless and non-invasive way of drug delivery. This greatly improves patient comfort and compliance, while reducing the risk of infection and other complications; the role of plasma and nanosecond pulsed electric fields in this targeted drug delivery system is to physically change the permeability of the skin and cells, thereby improving the permeability and absorption efficiency of drugs, while achieving precise and controllable drug release, and has the advantages of being painless and non-invasive. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 A schematic diagram of the system structure of a targeted drug delivery system utilizing plasma and nanosecond pulse electric field created by the present invention.

[0017] Figure 2The present invention provides a schematic diagram of the transdermal absorption of lidocaine hydrochloride injection on pig skin using a targeted drug delivery system using plasma and nanosecond pulse electric field, wherein (A) the permeability of lidocaine hydrochloride injection in the plasma treatment group and the control group at various time points. (B) the permeability of lidocaine hydrochloride injection in the plasma treatment group and the control group at various time points. (C) the skin retention of lidocaine hydrochloride injection in the plasma treatment group and the control group at various time points. (D) the skin retention rate of lidocaine hydrochloride injection in the plasma treatment group and the control group at various time points. DETAILED DESCRIPTION

[0018] In order to further explain the technical means and effects adopted by the present invention to achieve the predetermined invention purpose, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. The detailed description is as follows.

[0019] See also Figure 1 The present invention provides a technical solution: a targeted drug delivery system using plasma and nanosecond pulse electric field, including a control unit and a drug delivery handpiece, wherein the control unit controls the parameters of plasma generation and nanosecond pulse electric field application, such as frequency, voltage and duration, and the control unit is connected to a plasma generating component, and the control unit is connected to a drug supply component, and the plasma generating component and the drug supply component are respectively connected to the drug delivery handpiece, and are used to control the substance to be transdermally absorbed to enter the skin or subcutaneous tissue.

[0020] This embodiment is further configured such that the plasma generating component includes a nanosecond pulse generator, which provides a nanosecond pulse electric field, the nanosecond dosing generator is connected to a control unit, the nanosecond pulse generator is connected to a plasma generator, the plasma generator generates and maintains the required plasma, and the plasma generator is connected to a dosing handpiece.

[0021] This embodiment is further configured such that the drug supply component includes a data processing unit, which is connected to the control unit, and the data processing unit is connected to a drug supply unit for supplying drugs that need to be transdermally administered and delivering them to the vicinity of the plasma channel, and the drug supply unit is connected to a drug delivery handpiece.

[0022] This embodiment is further configured such that the data processing unit is connected to a user interaction unit, and the user interaction unit is provided with a touch panel.

[0023] This embodiment is further configured such that the control unit is connected to an electric energy supply component, the electric energy supply component includes a battery and a power supply, the control unit is connected to the battery, and the battery is connected to the power supply.

[0024] Nanosecond pulsed electric field (nsPEF) is a technology that uses extremely short pulse width (10-300ns) and high intensity (>10kV / cm) electric field to affect biological cells. Under the action of the electric field, the lipid bilayer membrane of the cell is rearranged to form hydrophilic micropores, which allow larger active agents such as peptides or proteins to penetrate into the cell efficiently under the electrophoresis of the electric field. At the same time, the electric field can also cause modulation inside the cell, allowing the active ingredients to more easily enter the cell organelles such as the nucleus, mitochondria, and endoplasmic reticulum.

[0025] By utilizing the conductive properties and controllability of plasma, high-voltage pulsed electric fields and currents can be applied to skin tissue. Under the action of instantaneous high-voltage pulsed current, the lipid bilayer structure temporarily forms reversible hydrophilic channels, thereby increasing the permeability of cell and tissue membranes. The particle activity of plasma can help retain the activity of the substances to be introduced and introduce hydrophilic groups on its surface, making these substances both water-soluble and fat-soluble. By utilizing the characteristics of active plasma particles, the hydrophilicity of the sebum layer and stratum corneum cells on the skin surface can also be enhanced, promoting the passage of active substances through physiological barriers, thereby achieving more effective drug delivery and skin treatment effects.

[0026] The detailed connection means are well known in the art; Figure 1 As shown, the system includes two main parts: a control unit and a drug delivery handpiece. The control unit is responsible for controlling the generation of plasma and the application parameters of the nanosecond pulse electric field, such as frequency, voltage and duration. The control unit is connected to the plasma generation component and the drug delivery component, and these two components are respectively connected to the drug delivery handpiece to control the entry of the substance to be transdermally absorbed into the skin or subcutaneous tissue.

[0027] In the system, the plasma generating component includes a nanosecond pulse generator, which provides a nanosecond pulse electric field. The nanosecond pulse generator is connected to the control unit and is connected to a plasma generator that produces the required plasma, thereby inducing the plasma generator to emit plasma. The drug supply component includes a data processing unit, which is connected to the control unit and is connected to a drug supply unit for supplying drugs that need to be transdermally administered and delivering them to the vicinity of the plasma generator. The drug supply unit is connected to a drug delivery handpiece. Under the action of plasma and pulse electric fields, the skin barrier opens, and the drug penetrates the skin to achieve targeted drug delivery. The control unit is also connected to a user interaction unit, which is provided with a touch panel.

[0028] In addition, the control unit is connected to an electric energy supply assembly, which includes a battery and a power source. The control unit is connected to the battery, and the battery is connected to the power source.

[0029] This system is designed to provide a more precise, easy-to-use and less irritating targeted drug delivery system by using nanosecond pulsed electric fields and plasma technology. Specific usage may involve adjusting system parameters, location and drug delivery method according to specific patient conditions, drug needs and treatment goals to achieve effective transdermal absorption and targeted treatment of drugs.

[0030] like Figure 2 The following is a specific experiment using lidocaine hydrochloride injection as an exploration of the application of plasma and nanosecond pulsed electric field technology in transdermal drug delivery. The performance of intradermal retention and transdermal penetration was quantitatively detected by high performance liquid chromatography (HPLC). After treatment with the plasma and nanosecond pulsed electric field device, the drug release and accumulation rate increased by about 2 times.

[0031]

[0032]

[0033] It should be noted that, in this document, relational terms such as first and second, etc. are merely used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any actual relationship or order between these entities or operations.

[0034] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Although the present invention has been disclosed as a preferred embodiment as above, it is not used to limit the present invention. Any technical personnel in this field can make some changes or modify the technical contents disclosed above into equivalent embodiments without departing from the scope of the technical solution of the present invention. However, any brief modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention are still within the scope of the technical solution of the present invention.

Claims

1. A targeted drug delivery system using plasma and nanosecond pulse electric field, comprising a control unit and a drug delivery handpiece, characterized in that: The control unit is connected to a plasma generating component, and the control unit is connected to a medicine supplying component. The plasma generating component and the medicine supplying component are respectively connected to the drug administering hand tool.

2. A targeted drug delivery system using plasma and nanosecond pulse electric field according to claim 1, characterized in that The plasma generating assembly includes a nanosecond pulse generator, the nanosecond dosing generator is connected to a control unit, the nanosecond pulse generator is connected to a plasma generator, and the plasma generator is connected to a dosing hand tool.

3. A targeted drug delivery system using plasma and nanosecond pulse electric field according to claim 1, characterized in that The drug supply component includes a data processing unit, which is connected to a control unit, and the data processing unit is connected to a drug supply unit, which is connected to a drug delivery device.

4. A targeted drug delivery system using plasma and nanosecond pulse electric field according to claim 3, characterized in that The data processing unit is connected to a user interaction unit, and the user interaction unit is provided with a touch panel.

5. The targeted drug delivery system using plasma and nanosecond pulse electric field according to claim 1, characterized in that The control unit is connected to an electric energy supply component, which includes a battery and a power supply. The control unit is connected to the battery, and the battery is connected to the power supply.